Macrophage migration inhibitory factor increases MMP-2 activity in DU-145 prostate cells

Cytokine

Volumn 12, Issue 7, 2000, Pages 914-921

  Meyer Siegler, Katherine ^a,b  

^a Bay Pines VA Medical Center   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cytokine; Macrophage migration inhibitory factor; Matrix metalloproteinase; Metastasis; Prostate cancer

Indexed keywords

GELATINASE A; MACROPHAGE MIGRATION INHIBITION FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; EPITHELIUM CELL; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE;

EID: 0033926165     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0682     Document Type: Article

References (33)

1. Bloom BR, Bennett B (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153: 80-82.
2. Weiser WY, Temple PA, Witek-Giannotti JS, Remold HG, Clark SC, David JR (1989) Molecular cloning of a cDNA encoding a human MIF. Proc Natl Acad Sci USA 86:7522-7526.
3. Wistow GJ, Shaughnessy MP, Lee DC, Hodin J, Zelenka PS (1993) A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc Natl Acad Sci USA 90:1271-1275.
4. Galat A, Riviere S, Bouet F (1993) Purification of macrophage migration inhibitory factor (MIF) from bovine brain cytosol. FEBS Lett 319:233-236.
5. Mitchell RA, Metz CN, Peng T, Bucala R (1999) Sustained Mitogen-activated Protein Kinase (MAPK) and Cytoplasmic Phospholipase A2 Activation by Macrophage Migration Inhibitory Factor (MIF). J Biol Chem 274:18100-18106.
6. Meyer-Siegler K, Hudson PB (1996) Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases. Urology 48:448-452.
7. Meyer-Siegler K, Fattor RA, Hudson PB (1998) Expression of macrophage migration inhibitory factor in the human prostate. Diagnostic Molecular Path 7:44-50.
8. Frenette G, Tremblay RR, Dube JY, Lazure C, Lemay M (1998) High concentrations of the macrophage migration inhibitory factor in human seminal plasma and prostatic tissues. Arch Androl 41:185-193.
9. Arcuri F, del Vecchio MT, de Santi MM, Lalinga AV, Pallini V, Bini L, Bartolommei S, Parigi S, Cintorino M (1999) Macrophage migration inhibitory factor in the human prostate: identification and immunocytochemical localization. Prostate 15:159-165.
10. Knabbe C, Kellner U, Schmahl M (1991) Growth factors in human prostate cancer cells: implications for an improved treatment of prostate cancer. J Steroid Biochem Mol Biol 40:185-192.
11. Calandra T, Bernhagen J, Metz CN (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68-71.
12. Rinker-Schaeffer CW, Partin AW, Isaacs WB (1994) Molecular and cellular changes associated with the acquisition of metastatic ability by prostate cancer cells. Prostate 25:249-265.
13. Stearns M, Stearns ME (1996) Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression. Oncol Res 8:69-75.
14. Gohji K, Fujimoto N, Hara I (1998) Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension. Int J Cancer 79:96-101.
15. Jung K, Lein M, Ulbrich N (1998) Quantification of matrix metalloproteinases and tissue inhibitors of metalloproteinase in prostatic tissue: analytical aspects. Prostate 34:130-136.
16. Takahashi N, Nishihira J, Sato Y, Knodo M, Ogawa H, Ohshima T, Une Y, Todo S (1998) Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol Med 4:707-714.
17. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R (1999) An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of murine lymphoma. Mol Med 5:181-191.
18. Wood M, Fudge K, Mohler JL (1997) In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin Exp Metastasis 15: 246-259.
19. Stearns ME, Rhim J, Wang M (1999) Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. Clin Cancer Res 5:189-196.
20. Woessner JF Jr (1995) Quantification of matrix metalloproteinases in tissue samples. Meth Enzymol 248:510-528.
21. Brown PD, Levy AT, Margulies IMK, Liotta LA (1990) Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50:6184-6191.
22. Cooper CR, Donald C, Emmett N, Harris-Hooker S, Cooke DB (1993) Adhesion and invasion potential of rat prostatic cancer cells: Correlation with metastatic potential. Invasion Metastasis 13:178-184.
23. Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R (1996) An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 93:7849-7854.
24. Waeber G, Calandra T, Roduit R, Haefliger J-A, Bonny C, Thompson N (1997) Insulin secretion is regulated by the glucose-dependent production of islet ß cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA 94:4782-4787.
25. Meinhardt A, Bacher M, McFarlane JR (1996) Macrophage migration inhibitory factor production by Leydig cells: Evidence for a role in the regulation of testicular function. Endocrinology 137:5090-5095.
26. Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179: 1895-1902.
27. Lanahan A, Williams JB, Sanders LK, Nathans D (1992) Growth factor-induced delayed early response genes. Mol Cell Biol 12:3919-3929.
28. Magi B, Bini L, Liberatori S, Marzocchi B, Raggiaschi R, Arcuri F, Tripodi SA, Cintorino M, Tosi P, Pallini V (1998) Charge heterogeneity of macrophage migration inhibitory factor (MIF) in human liver and breast tissue. Electrophoresis 19:2010-2013.
29. Kozak CA, Adamson MC, Buckler CE, Segovia L, Paralkar V, Wistow G (1995) Genomic cloning of mouse MIF (Macrophage Inhibitory Factor) and genetic mapping of the human and mouse expressed gene and nine mouse pseudogenes. Genomics 27:405-411.
30. Bini L, Magi B, Marzocchi B (1997) Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 18:2832-2841.
31. Shimizu T, Abe R, Nakamura H, Ohkawara A, Suzuki M, Nishihira J (1999) High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem Biophys Res Comm 264:751-758.
32. Stearns M, Wang M, Stearns ME (1995) Cytokine (IL-10, IL-6) induction of tissue inhibitor of metalloproteinase 1 in primary human prostate tumor cell lines. Oncol Res 7:173-181.
33. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J (2000) Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 275:444-450.